Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes

M. Shoji, K. Kobayashi, M. Takemoto, Yasunori Sato, K. Yokote

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetic nephropathy has dramatically increased worldwide. In this study, we measured urinary podocalyxin in 240 patients with diabetes. The relationship between urinary podocalyxin and clinical parameters and the effects of dipeptidyl peptidase-4 inhibitors (DPP4i) and alpha-glucosidase inhibitor (a-GI) on urinary podocalyxin levels were examined. Urinary podocalyxin levels were significantly higher in patients with microalbuminuria than in those with normoalbuminuria. Urinary podocalyxin levels were also significantly related to albumin-to-creatinine ratio. Neither DPP4i nor α-GI ameliorated the increase in urinary podocalyxin levels. Our results indicated that urinary podocalyxin will be not only an early marker but also a treatment target for DN.

Original languageEnglish
Pages (from-to)164-167
Number of pages4
JournalBiomarkers
Volume21
Issue number2
DOIs
Publication statusPublished - 2016 Feb 17
Externally publishedYes

Fingerprint

Medical problems
Albumins
Dipeptidyl-Peptidase IV Inhibitors
Diabetic Nephropathies
podocalyxin
Creatinine

Keywords

  • Biomarker
  • diabetic nephropathy
  • podocyte
  • urinary podocalyxin

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes. / Shoji, M.; Kobayashi, K.; Takemoto, M.; Sato, Yasunori; Yokote, K.

In: Biomarkers, Vol. 21, No. 2, 17.02.2016, p. 164-167.

Research output: Contribution to journalArticle

Shoji, M. ; Kobayashi, K. ; Takemoto, M. ; Sato, Yasunori ; Yokote, K. / Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes. In: Biomarkers. 2016 ; Vol. 21, No. 2. pp. 164-167.
@article{58d6604ced554063a7ea7653d7c06853,
title = "Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes",
abstract = "Diabetic nephropathy has dramatically increased worldwide. In this study, we measured urinary podocalyxin in 240 patients with diabetes. The relationship between urinary podocalyxin and clinical parameters and the effects of dipeptidyl peptidase-4 inhibitors (DPP4i) and alpha-glucosidase inhibitor (a-GI) on urinary podocalyxin levels were examined. Urinary podocalyxin levels were significantly higher in patients with microalbuminuria than in those with normoalbuminuria. Urinary podocalyxin levels were also significantly related to albumin-to-creatinine ratio. Neither DPP4i nor α-GI ameliorated the increase in urinary podocalyxin levels. Our results indicated that urinary podocalyxin will be not only an early marker but also a treatment target for DN.",
keywords = "Biomarker, diabetic nephropathy, podocyte, urinary podocalyxin",
author = "M. Shoji and K. Kobayashi and M. Takemoto and Yasunori Sato and K. Yokote",
year = "2016",
month = "2",
day = "17",
doi = "10.3109/1354750X.2015.1118551",
language = "English",
volume = "21",
pages = "164--167",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes

AU - Shoji, M.

AU - Kobayashi, K.

AU - Takemoto, M.

AU - Sato, Yasunori

AU - Yokote, K.

PY - 2016/2/17

Y1 - 2016/2/17

N2 - Diabetic nephropathy has dramatically increased worldwide. In this study, we measured urinary podocalyxin in 240 patients with diabetes. The relationship between urinary podocalyxin and clinical parameters and the effects of dipeptidyl peptidase-4 inhibitors (DPP4i) and alpha-glucosidase inhibitor (a-GI) on urinary podocalyxin levels were examined. Urinary podocalyxin levels were significantly higher in patients with microalbuminuria than in those with normoalbuminuria. Urinary podocalyxin levels were also significantly related to albumin-to-creatinine ratio. Neither DPP4i nor α-GI ameliorated the increase in urinary podocalyxin levels. Our results indicated that urinary podocalyxin will be not only an early marker but also a treatment target for DN.

AB - Diabetic nephropathy has dramatically increased worldwide. In this study, we measured urinary podocalyxin in 240 patients with diabetes. The relationship between urinary podocalyxin and clinical parameters and the effects of dipeptidyl peptidase-4 inhibitors (DPP4i) and alpha-glucosidase inhibitor (a-GI) on urinary podocalyxin levels were examined. Urinary podocalyxin levels were significantly higher in patients with microalbuminuria than in those with normoalbuminuria. Urinary podocalyxin levels were also significantly related to albumin-to-creatinine ratio. Neither DPP4i nor α-GI ameliorated the increase in urinary podocalyxin levels. Our results indicated that urinary podocalyxin will be not only an early marker but also a treatment target for DN.

KW - Biomarker

KW - diabetic nephropathy

KW - podocyte

KW - urinary podocalyxin

UR - http://www.scopus.com/inward/record.url?scp=84949236070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949236070&partnerID=8YFLogxK

U2 - 10.3109/1354750X.2015.1118551

DO - 10.3109/1354750X.2015.1118551

M3 - Article

VL - 21

SP - 164

EP - 167

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 2

ER -